Sinopharm Tech Holdings Second Quarter 2024 Earnings: HK$0.003 loss per share (vs HK$0.061 profit in 2Q 2023)

Simply Wall St

March 02, 2024

Sinopharm Tech Holdings (HKG:8156) Second Quarter 2024 Results

Key Financial Results

Revenue: HK$14.9m (up 58% from 2Q 2023).
Net loss: HK$533.0k (down by 105% from HK$11.0m profit in 2Q 2023).
HK$0.003 loss per share (down from HK$0.061 profit in 2Q 2023).

earnings-and-revenue-history — SEHK:8156 Earnings and Revenue History March 2nd 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Sinopharm Tech Holdings shares are up 13% from a week ago.

Risk Analysis

You should learn about the 2 warning signs we've spotted with Sinopharm Tech Holdings.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.